Elsevier’s Pathway Studio helps you interpret your experimental data, and get a more complete picture of the underlying biology of diseases, responses to drugs, and a wide range of biological processes.
Pathway Studio News: October
Key Opinion Leader Webinar
Attend a seminar on Immuno-oncology therapeutics and learn about new innovations, preclinical and clinical trial issues and discovery of novel immune-therapy drug targets. Read more Sept 12, 2017 at 11 AM EDT Register today.
New Case Study: Target Identification and Prioritization using Pathway Studio
A Pathway Studio workflow is discussed that uses Curated Pathways as scaffolds, and, current published literature coupled with experimental data to define a de novo disease model containing novel and known targets. Read the paper